Rossari Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,109	753.07	442.02	251.7	691.98	374.77
Short-Term Investments	364.24	44.01	44.38	80.62	550.64	149.64
Trading Asset Securities	-	351	573.13	375.83	259.95	119.85
Cash & Short-Term Investments	1,473	1,148	1,060	708.15	1,503	644.26
Cash Growth	91.81%	8.36%	49.62%	-52.87%	133.22%	-27.08%
Accounts Receivable	5,537	5,574	4,745	4,251	3,537	3,049
Other Receivables	-	1.48	2.82	1.54	5.41	1.16
Receivables	5,547	5,587	4,760	4,260	3,545	3,064
Inventory	4,440	4,045	3,551	2,823	1,885	1,899
Prepaid Expenses	-	35.91	20.11	12.48	18.31	49.49
Other Current Assets	1,547	1,542	1,029	631.99	263.62	436.26
Total Current Assets	13,007	12,359	10,419	8,436	7,214	6,093
Property, Plant & Equipment	7,587	7,338	4,937	3,619	3,267	3,480
Long-Term Investments	376.23	278.44	267.71	253.55	251.8	245.47
Goodwill	1,187	1,187	1,187	1,187	1,187	898.58
Other Intangible Assets	957.66	1,052	1,261	1,442	1,559	1,706
Long-Term Deferred Tax Assets	172.43	149.43	105.13	48.1	31.99	13.53
Other Long-Term Assets	307.88	523.53	784.41	736.46	164.48	130.46
Total Assets	23,595	22,888	18,962	15,722	13,676	12,567

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	3,436	3,235	2,863	2,191	1,810	1,862
Accrued Expenses	-	74.36	54.21	33.37	95.2	97.33
Short-Term Debt	-	2,837	754.52	625.28	290.12	-
Current Portion of Long-Term Debt	2,797	299.46	124.89	99.75	99.83	84.27
Current Portion of Leases	91.13	76.98	77.18	20.59	-	-
Current Income Taxes Payable	118.45	90	122.47	101.01	84.63	71.83
Current Unearned Revenue	-	3.32	3.61	3.9	4.19	4.48
Other Current Liabilities	1,587	1,280	1,365	1,173	1,101	827.22
Total Current Liabilities	8,029	7,896	5,366	4,247	3,485	2,947
Long-Term Debt	820.81	943.26	1,000	333.24	349.33	-
Long-Term Leases	171.71	202.53	223.07	109.06	-	-
Pension & Post-Retirement Benefits	95.05	82.6	52.57	34.24	21.82	17.82
Long-Term Deferred Tax Liabilities	402.11	430.46	465.67	514.72	587.2	689.49
Other Long-Term Liabilities	-	-	-	5.6	80.56	861.63
Total Liabilities	9,519	9,554	7,107	5,244	4,524	4,516

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	110.79	110.77	110.73	110.49	110.31	110.11
Additional Paid-In Capital	-	4,732	4,751	4,686	4,641	4,591
Retained Earnings	-	8,438	6,972	5,645	4,366	3,318
Comprehensive Income & Other	13,965	53.3	21.14	35.36	35.03	32.85
Shareholders' Equity	14,076	13,333	11,854	10,477	9,152	8,052
Total Liabilities & Equity	23,595	22,888	18,962	15,722	13,676	12,567

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	3,881	4,359	2,180	1,188	739.28	84.27
Net Cash (Debt)	-2,408	-3,211	-1,120	-479.77	763.29	559.99
Net Cash Growth	-	-	-	-	36.30%	-36.62%
Net Cash Per Share	-43.42	-57.95	-20.24	-8.67	13.79	10.15
Filing Date Shares Outstanding	55.42	55.38	55.36	55.25	55.16	55.06
Total Common Shares Outstanding	55.42	55.38	55.36	55.25	55.16	55.06
Working Capital	4,978	4,463	5,054	4,188	3,729	3,146
Book Value Per Share	253.97	240.75	214.12	189.65	165.92	146.24
Tangible Book Value	11,931	11,094	9,406	7,849	6,405	5,447
Tangible Book Value Per Share	215.27	200.32	169.90	142.07	116.13	98.93
Land	-	101.42	101.42	101.42	101.42	101.42
Buildings	-	1,732	1,697	1,666	1,693	1,670
Machinery	-	5,075	2,904	2,379	2,114	2,056
Construction In Progress	-	1,733	1,402	472.09	130.72	13.42
Leasehold Improvements	-	83.37	81.02	-	-	-